# reload+after+2024-01-22 08:45:07.125814
address1§201 Haskins Way
address2§Suite 210
city§South San Francisco
state§CA
zip§94080
country§United States
phone§650 484 0886
website§https://graphitebio.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. It offers GPH102 for the treatment of beta-thalassemia; GPH201 for the treatment of X-linked severe combined immunodeficiency syndrome; and GPH301, a product candidate for the treatment of Gaucher disease, a genetic disorder that results in a deficiency in the glucocerebrosidase enzyme. The company was formerly known as Integral Medicines, Inc., and changed its name to Graphite Bio, Inc. in August 2020. Graphite Bio, Inc. was incorporated in 2017 and is headquartered in South San Francisco, California.
fullTimeEmployees§120
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Matthew  Porteus M.D., Ph.D.', 'age': 58, 'title': 'Academic Founder & Director', 'yearBorn': 1965, 'fiscalYear': 2022, 'totalPay': 110000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Kimberlee Cobleigh Drapkin CPA', 'age': 55, 'title': 'President, CEO, COO, Principal Executive, Financial & Accounting Officer and Director', 'yearBorn': 1968, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Stephanie  Yao', 'title': 'Vice President of Communications & Investor Relations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Christine  Garrett P.M.P., Ph.D.', 'age': 52, 'title': 'Chief Strategy Officer', 'yearBorn': 1971, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§8
boardRisk§5
compensationRisk§9
shareHolderRightsRisk§8
overallRisk§7
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§0.031
currency§USD
dateShortInterest§1702598400
forwardEps§-0.4
pegRatio§-0.06
exchange§NGM
quoteType§EQUITY
shortName§Graphite Bio, Inc.
longName§Graphite Bio, Inc.
firstTradeDateEpochUtc§1624627800
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§0e2cca8f-1aec-3e6d-80d3-39814500dbb7
gmtOffSetMilliseconds§-18000000
targetHighPrice§7.0
targetLowPrice§7.0
targetMeanPrice§7.0
targetMedianPrice§7.0
recommendationMean§3.0
recommendationKey§hold
numberOfAnalystOpinions§1
quickRatio§18.664
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
